Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Daniela Cecconi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7314-8941; OpenAlex author ID A5007177776. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 14

  1. Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1111/febs.70223↗
  2. Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1038/s41419-025-08082-1↗
  3. Triphenylphosphonium-Conjugated Palmitic Acid for Mitochondrial Targeting of Pancreatic Cancer Cells: Proteomic and Molecular Evidence. Last author DOI 10.3390/ijms25126790↗
  4. Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC. Co-author DOI 10.3390/biom12020305↗
  5. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells. Last author DOI 10.1038/s41598-021-92752-5↗
  6. The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/biom10060884↗
  7. Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem State. Co-author DOI 10.3390/cells9071572↗
  8. Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study. Co-author DOI 10.1002/jcb.26436↗
  9. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. Last author DOI 10.4252/wjsc.v10.i11.172↗
  10. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways. Co-author DOI 10.1016/j.jprot.2016.10.002↗
  11. Secretome protein signature of human pancreatic cancer stem-like cells. Last author DOI 10.1016/j.jprot.2016.01.017↗
  12. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Co-author DOI 10.3892/ijo.2014.2796↗
  13. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists. Last author DOI 10.1002/elps.201200402↗
  14. Proteomics in pancreatic cancer research. Co-author DOI 10.1002/pmic.201000401↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jessica Brandi · 12 shared papers, 2013–2025 · strength 1.35
  2. Massimo Donadelli · 7 shared papers, 2011–2026 · strength 0.89
  3. Raffaella Pacchiana · 4 shared papers, 2018–2026 · strength 0.69
  4. Emílio Marengo · 5 shared papers, 2016–2022 · strength 0.50
  5. Adriana Celesia · 2 shared papers, 2025–2026 · strength 0.47
  6. Alessandra Fiore · 2 shared papers, 2025–2026 · strength 0.47
  7. Federica Danzi · 2 shared papers, 2025–2026 · strength 0.47
  8. Marta Palmieri · 7 shared papers, 2011–2021 · strength 0.47
  9. Elisa Dalla Pozza · 6 shared papers, 2015–2021 · strength 0.46
  10. Aldo Scarpa Scarpa · 5 shared papers, 2015–2025 · strength 0.45
  11. Giovanna Butera · 3 shared papers, 2020–2025 · strength 0.43
  12. Ilaria Dando · 6 shared papers, 2013–2021 · strength 0.42
  13. Claudia Di Carlo · 3 shared papers, 2018–2021 · strength 0.35
  14. Giuliana Siragusa · 1 shared paper, 2024 · strength 0.28
  15. Maria Poles · 1 shared paper, 2026 · strength 0.28
  16. Antonio Pea · 1 shared paper, 2025 · strength 0.19
  17. Claudio Luchini · 1 shared paper, 2025 · strength 0.19
  18. Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.19
  19. Roberto Salvia · 1 shared paper, 2025 · strength 0.19
  20. Giulia Biondani · 3 shared papers, 2015–2017 · strength 0.16
  21. Eithne Costello · 2 shared papers, 2016–2017 · strength 0.11
  22. Rita Teresa Lawlor · 1 shared paper, 2020 · strength 0.11
  23. Cristian Andres Carmona‐Carmona · 1 shared paper, 2020 · strength 0.09
  24. Giulia Ambrosini · 1 shared paper, 2020 · strength 0.09
  25. Matteo Fassan · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.